How have AVO shares performed in 2024?

Advanced Oncotherapy's stock was trading at GBX 1.75 on January 1st, 2024. Since then, AVO shares have increased by 0.0% and is now trading at GBX 1.75. View the best growth stocks for 2024 here .

How were Advanced Oncotherapy's earnings last quarter?

Advanced Oncotherapy plc (LON:AVO) announced its quarterly earnings data on Monday, June, 29th. The company reported ($9.83) EPS for the quarter, missing analysts' consensus estimates of ($8.90) by $0.93.

What other stocks do shareholders of Advanced Oncotherapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Advanced Oncotherapy investors own include UK Oil & Gas (UKOG) , Oxford Biomedica (OXB) , BMR Group (BMR) , GW Pharmaceuticals (GWPH) , Lancashire (LRE) , Sirius Minerals (SXX) , Renishaw (RSW) , Scancell (SCLP) and Tullow Oil (TLW) .

How do I buy shares of Advanced Oncotherapy?

Shares of AVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:AVO

Advanced Oncotherapy (AVO) Share Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free AVO Stock Alerts

GBX 1.75

-0.18 (-9.09%)

(As of 08/30/2023)

Compare

Today's Range: 1.75
▼
1.75
50-Day Range: 1.75
▼
1.75
52-Week Range: 1.75
▼
25.75

Volume: 200,000 shs
Average Volume: 1.27 million shs
Market Capitalization: £9.49 million

P/E Ratio: N/A
Dividend Yield: 5.49%
Price Target: N/A

Stock Analysis Insider Trades

Get Advanced Oncotherapy alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Advanced Oncotherapy Stock (LON:AVO)

Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

AVO Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AVO Stock News Headlines

April 10, 2024 | americanbankingnews.com

Advanced Oncotherapy (LON:AVO) Share Price Crosses Above 50 Day Moving Average of $1.75

January 23, 2024 | lse.co.uk

Advanced Oncotherapy Share Chat

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

December 9, 2023 | morningstar.com

Advanced Oncotherapy PLC AVO

June 12, 2023 | finance.yahoo.com

Favourable Signals For Advanced Oncotherapy: Numerous Insiders Acquired Stock

June 12, 2023 | finance.yahoo.com

Favourable Signals For Advanced Oncotherapy: Numerous Insiders Acquired Stock \

January 27, 2023 | finanznachrichten.de

Hardman & Co Research: Q&A on Advanced Oncotherapy (AVO): Current EV significantly below cumulative investment to date

January 3, 2023 | finance.yahoo.com

Independent Non-Executive Director Michael Bradfield Just Bought 6.4% More Shares In Advanced Oncotherapy plc (LON:AVO)

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

December 13, 2022 | marketwatch.com

Advanced Oncotherapy Raises GBP1.5 Mln Via High-Premium Share Subscription

October 27, 2022 | proactiveinvestors.com

Proactive news headlines: Deepverge, Greatland Gold, Seeing Machines, and more

September 29, 2022 | uk.finance.yahoo.com

Hardman & Co Research on Advanced Oncotherapy: Major milestone achieved

September 8, 2022 | finance.yahoo.com

Advanced Oncotherapy plc (LON:AVO) has caught the attention of institutional investors who hold a sizeable 39% stake

August 1, 2022 | finance.yahoo.com

Is Now An Opportune Moment To Examine Advanced Oncotherapy plc (LON:AVO)?

July 2, 2022 | finance.yahoo.com

Calculating The Intrinsic Value Of Advanced Oncotherapy plc (LON:AVO)

March 31, 2022 | proactiveinvestors.com

Advanced Oncotherapy's technology can slash costs of proton therapy cancer treatment says CEO

March 26, 2022 | proactiveinvestors.com.au

Proactive weekly mining highlights: Horizonte, Atlantic Lithium, East Star and more

March 25, 2022 | proactiveinvestors.com

Advanced Oncotherapy raises £2mln at a premium

March 1, 2022 | proactiveinvestors.com

FTSE 100 in the red as fighting in Ukraine is intensifying with Russia

March 1, 2022 | proactiveinvestors.com

Advanced Oncotherapy hails significant progress with regulatory submission as it updates on its timeline

February 25, 2022 | finance.yahoo.com

Advanced Oncotherapy plc (AVO.L)

December 13, 2021 | proactiveinvestors.com

Advanced Oncotherapy says it is making good progress, but confirms previously-flagged delay

November 15, 2021 | markets.businessinsider.com

Hardman & Co Research: Advanced Oncotherapy (AVO): On the home straight

October 2, 2021 | finance.yahoo.com

Is Advanced Oncotherapy plc (LON:AVO) Popular Amongst Insiders?

September 2, 2021 | proactiveinvestors.com

Advanced Oncotherapy - Result of GM, TVR and clarification re warrants

August 12, 2021 | markets.businessinsider.com

Advanced Oncotherapy : Result of AGM

August 12, 2021 | finanznachrichten.de

Hardman & Co Research: Advanced Oncotherapy (AVO) Funded to completion

See More Headlines

Receive AVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 6/29/2020
Today: 4/18/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: LON:AVO
CUSIP: N/A
CIK: N/A
Web: www.advancedoncotherapy.com
Phone: +44-20-36178728
Fax: N/A
Employees: 174
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX (0.07)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-32,600,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -67.34%
Return on Assets: -11.73%

Debt

Debt-to-Equity Ratio: 98.71
Current Ratio: 1.26
Quick Ratio: 0.13

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: GBX 0.05 per share
Price / Cash Flow: 33.50
Book Value: GBX 14 per share
Price / Book: 0.13

Miscellaneous

Outstanding Shares: 542,570,000
Free Float: N/A
Market Cap: £9.49 million
Optionable: Not Optionable
Beta: 0.09

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Dr. Michael Jeffrey Sinclair (Age 82)
Executive Chairman
Comp: $434.42k
Mr. Nicolas Serandour (Age 49)
CEO & Executive Director
Comp: $502.96k
Prof. Stephen Myers OBE (Age 78)
Executive Director
Comp: $397.72k
Mr. Ed Lee
COO & President of Europe
Mr. Graham Pughe
Senior Vice-President of Accounting
Ms. Berengere Pons-Chabord
Senior Vice-President of Corporate Finance
Mr. David Navas
Vice President of Investor and Public Relations
Ms. Bridget Biggar
Director of Human Resources
Ms. Donatella Ungaro
Managing Director of ADAM
Ms. Marina Giunta
Head of Physics Group

Key Competitors

View All Competitors

AVO Stock Analysis - Frequently Asked Questions

How have AVO shares performed in 2024?: Advanced Oncotherapy's stock was trading at GBX 1.75 on January 1st, 2024. Since then, AVO shares have increased by 0.0% and is now trading at GBX 1.75.
View the best growth stocks for 2024 here.
How were Advanced Oncotherapy's earnings last quarter?: Advanced Oncotherapy plc (LON:AVO) announced its quarterly earnings data on Monday, June, 29th. The company reported ($9.83) EPS for the quarter, missing analysts' consensus estimates of ($8.90) by $0.93.
What other stocks do shareholders of Advanced Oncotherapy own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Advanced Oncotherapy investors own include UK Oil & Gas (UKOG), Oxford Biomedica (OXB), BMR Group (BMR), GW Pharmaceuticals (GWPH), Lancashire (LRE), Sirius Minerals (SXX), Renishaw (RSW), Scancell (SCLP) and Tullow Oil (TLW).
How do I buy shares of Advanced Oncotherapy?: Shares of AVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:AVO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial